Go Pro

Inspira Technologies OXY B.H.N. (QTEX) Competitors

Inspira Technologies OXY B.H.N. logo
$0.93 +0.08 (+9.05%)
As of 01:40 PM Eastern

QTEX vs. APYX, MBOT, KEQU, LUNG, and HYPR

Should you buy Inspira Technologies OXY B.H.N. stock or one of its competitors? Inspira Technologies OXY B.H.N.'s main competitors and comparable companies include Apyx Medical (APYX), Microbot Medical (MBOT), Kewaunee Scientific (KEQU), Pulmonx (LUNG), and Hyperfine (HYPR). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does Inspira Technologies OXY B.H.N. compare to Apyx Medical?

Apyx Medical (NASDAQ:APYX) and Inspira Technologies OXY B.H.N. (NASDAQ:QTEX) are both small-cap healthcare companies, but which is the better business? We will compare the two companies based on the strength of their valuation, earnings, institutional ownership, profitability, dividends, risk, analyst recommendations and media sentiment.

Apyx Medical has a beta of 1.39, meaning that its stock price is 39% more volatile than the broader market. Comparatively, Inspira Technologies OXY B.H.N. has a beta of 4.24, meaning that its stock price is 324% more volatile than the broader market.

Inspira Technologies OXY B.H.N. has a net margin of 0.00% compared to Apyx Medical's net margin of -14.78%. Inspira Technologies OXY B.H.N.'s return on equity of 0.00% beat Apyx Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Apyx Medical-14.78% -76.60% -13.91%
Inspira Technologies OXY B.H.N. N/A N/A N/A

In the previous week, Inspira Technologies OXY B.H.N. had 1 more articles in the media than Apyx Medical. MarketBeat recorded 2 mentions for Inspira Technologies OXY B.H.N. and 1 mentions for Apyx Medical. Apyx Medical's average media sentiment score of 0.92 beat Inspira Technologies OXY B.H.N.'s score of 0.00 indicating that Apyx Medical is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Apyx Medical
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Inspira Technologies OXY B.H.N.
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Apyx Medical has higher revenue and earnings than Inspira Technologies OXY B.H.N..

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Apyx Medical$58.42M2.20-$11.21M-$0.20N/A
Inspira Technologies OXY B.H.N.$290K115.02-$13.22MN/AN/A

55.3% of Apyx Medical shares are held by institutional investors. Comparatively, 12.7% of Inspira Technologies OXY B.H.N. shares are held by institutional investors. 15.9% of Apyx Medical shares are held by insiders. Comparatively, 29.4% of Inspira Technologies OXY B.H.N. shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Apyx Medical currently has a consensus price target of $6.60, suggesting a potential upside of 116.39%. Given Apyx Medical's stronger consensus rating and higher possible upside, equities research analysts clearly believe Apyx Medical is more favorable than Inspira Technologies OXY B.H.N..

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Apyx Medical
1 Sell rating(s)
1 Hold rating(s)
4 Buy rating(s)
1 Strong Buy rating(s)
2.71
Inspira Technologies OXY B.H.N.
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Summary

Apyx Medical beats Inspira Technologies OXY B.H.N. on 8 of the 15 factors compared between the two stocks.

How does Inspira Technologies OXY B.H.N. compare to Microbot Medical?

Microbot Medical (NASDAQ:MBOT) and Inspira Technologies OXY B.H.N. (NASDAQ:QTEX) are both small-cap healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, analyst recommendations, dividends, media sentiment, institutional ownership, earnings, risk and valuation.

In the previous week, Microbot Medical had 7 more articles in the media than Inspira Technologies OXY B.H.N.. MarketBeat recorded 9 mentions for Microbot Medical and 2 mentions for Inspira Technologies OXY B.H.N.. Inspira Technologies OXY B.H.N.'s average media sentiment score of 0.00 beat Microbot Medical's score of -0.50 indicating that Inspira Technologies OXY B.H.N. is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Microbot Medical
0 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Negative
Inspira Technologies OXY B.H.N.
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

16.3% of Microbot Medical shares are held by institutional investors. Comparatively, 12.7% of Inspira Technologies OXY B.H.N. shares are held by institutional investors. 4.7% of Microbot Medical shares are held by insiders. Comparatively, 29.4% of Inspira Technologies OXY B.H.N. shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Microbot Medical has higher earnings, but lower revenue than Inspira Technologies OXY B.H.N..

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Microbot MedicalN/AN/A-$13.14M-$0.24N/A
Inspira Technologies OXY B.H.N.$290K115.02-$13.22MN/AN/A

Microbot Medical has a beta of 1.06, meaning that its share price is 6% more volatile than the broader market. Comparatively, Inspira Technologies OXY B.H.N. has a beta of 4.24, meaning that its share price is 324% more volatile than the broader market.

Microbot Medical presently has a consensus price target of $6.38, indicating a potential upside of 323.59%. Given Microbot Medical's stronger consensus rating and higher possible upside, analysts clearly believe Microbot Medical is more favorable than Inspira Technologies OXY B.H.N..

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Microbot Medical
1 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
1 Strong Buy rating(s)
2.80
Inspira Technologies OXY B.H.N.
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Inspira Technologies OXY B.H.N.'s return on equity of 0.00% beat Microbot Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Microbot MedicalN/A -21.87% -20.76%
Inspira Technologies OXY B.H.N. N/A N/A N/A

Summary

Microbot Medical beats Inspira Technologies OXY B.H.N. on 7 of the 13 factors compared between the two stocks.

How does Inspira Technologies OXY B.H.N. compare to Kewaunee Scientific?

Kewaunee Scientific (NASDAQ:KEQU) and Inspira Technologies OXY B.H.N. (NASDAQ:QTEX) are both small-cap healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their dividends, earnings, analyst recommendations, institutional ownership, risk, media sentiment, profitability and valuation.

Kewaunee Scientific has a beta of 0.72, meaning that its stock price is 28% less volatile than the broader market. Comparatively, Inspira Technologies OXY B.H.N. has a beta of 4.24, meaning that its stock price is 324% more volatile than the broader market.

32.7% of Kewaunee Scientific shares are owned by institutional investors. Comparatively, 12.7% of Inspira Technologies OXY B.H.N. shares are owned by institutional investors. 14.1% of Kewaunee Scientific shares are owned by company insiders. Comparatively, 29.4% of Inspira Technologies OXY B.H.N. shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Kewaunee Scientific has higher revenue and earnings than Inspira Technologies OXY B.H.N..

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Kewaunee Scientific$282M0.37$9.62M$3.2211.35
Inspira Technologies OXY B.H.N.$290K115.02-$13.22MN/AN/A

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Kewaunee Scientific
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00
Inspira Technologies OXY B.H.N.
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Kewaunee Scientific has a net margin of 3.41% compared to Inspira Technologies OXY B.H.N.'s net margin of 0.00%. Kewaunee Scientific's return on equity of 14.10% beat Inspira Technologies OXY B.H.N.'s return on equity.

Company Net Margins Return on Equity Return on Assets
Kewaunee Scientific3.41% 14.10% 5.55%
Inspira Technologies OXY B.H.N. N/A N/A N/A

In the previous week, Inspira Technologies OXY B.H.N. had 2 more articles in the media than Kewaunee Scientific. MarketBeat recorded 2 mentions for Inspira Technologies OXY B.H.N. and 0 mentions for Kewaunee Scientific. Kewaunee Scientific's average media sentiment score of 0.00 equaled Inspira Technologies OXY B.H.N.'saverage media sentiment score.

Company Overall Sentiment
Kewaunee Scientific Neutral
Inspira Technologies OXY B.H.N. Neutral

Summary

Kewaunee Scientific beats Inspira Technologies OXY B.H.N. on 7 of the 11 factors compared between the two stocks.

How does Inspira Technologies OXY B.H.N. compare to Pulmonx?

Pulmonx (NASDAQ:LUNG) and Inspira Technologies OXY B.H.N. (NASDAQ:QTEX) are both small-cap healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their risk, earnings, analyst recommendations, institutional ownership, profitability, dividends, media sentiment and valuation.

Pulmonx has a beta of 0.28, meaning that its stock price is 72% less volatile than the broader market. Comparatively, Inspira Technologies OXY B.H.N. has a beta of 4.24, meaning that its stock price is 324% more volatile than the broader market.

Inspira Technologies OXY B.H.N. has lower revenue, but higher earnings than Pulmonx.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Pulmonx$87.44M1.14-$54M-$1.16N/A
Inspira Technologies OXY B.H.N.$290K115.02-$13.22MN/AN/A

In the previous week, Pulmonx and Pulmonx both had 2 articles in the media. Pulmonx's average media sentiment score of 0.86 beat Inspira Technologies OXY B.H.N.'s score of 0.00 indicating that Pulmonx is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Pulmonx
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Inspira Technologies OXY B.H.N.
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Inspira Technologies OXY B.H.N. has a net margin of 0.00% compared to Pulmonx's net margin of -55.03%. Inspira Technologies OXY B.H.N.'s return on equity of 0.00% beat Pulmonx's return on equity.

Company Net Margins Return on Equity Return on Assets
Pulmonx-55.03% -96.66% -38.32%
Inspira Technologies OXY B.H.N. N/A N/A N/A

Pulmonx presently has a consensus price target of $7.67, suggesting a potential upside of 230.46%. Given Pulmonx's stronger consensus rating and higher possible upside, research analysts plainly believe Pulmonx is more favorable than Inspira Technologies OXY B.H.N..

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Pulmonx
1 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.50
Inspira Technologies OXY B.H.N.
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

91.0% of Pulmonx shares are owned by institutional investors. Comparatively, 12.7% of Inspira Technologies OXY B.H.N. shares are owned by institutional investors. 7.5% of Pulmonx shares are owned by insiders. Comparatively, 29.4% of Inspira Technologies OXY B.H.N. shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Summary

Inspira Technologies OXY B.H.N. beats Pulmonx on 7 of the 13 factors compared between the two stocks.

How does Inspira Technologies OXY B.H.N. compare to Hyperfine?

Hyperfine (NASDAQ:HYPR) and Inspira Technologies OXY B.H.N. (NASDAQ:QTEX) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, dividends, risk, earnings, profitability, media sentiment and valuation.

15.0% of Hyperfine shares are owned by institutional investors. Comparatively, 12.7% of Inspira Technologies OXY B.H.N. shares are owned by institutional investors. 26.3% of Hyperfine shares are owned by company insiders. Comparatively, 29.4% of Inspira Technologies OXY B.H.N. shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Hyperfine presently has a consensus target price of $2.03, indicating a potential upside of 125.00%. Given Hyperfine's stronger consensus rating and higher possible upside, research analysts clearly believe Hyperfine is more favorable than Inspira Technologies OXY B.H.N..

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Hyperfine
1 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.40
Inspira Technologies OXY B.H.N.
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Inspira Technologies OXY B.H.N. has lower revenue, but higher earnings than Hyperfine.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Hyperfine$11.40M8.41-$35.57M-$0.38N/A
Inspira Technologies OXY B.H.N.$290K115.02-$13.22MN/AN/A

Hyperfine has a beta of 1.42, indicating that its share price is 42% more volatile than the broader market. Comparatively, Inspira Technologies OXY B.H.N. has a beta of 4.24, indicating that its share price is 324% more volatile than the broader market.

In the previous week, Hyperfine and Hyperfine both had 2 articles in the media. Hyperfine's average media sentiment score of 0.91 beat Inspira Technologies OXY B.H.N.'s score of 0.00 indicating that Hyperfine is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Hyperfine
2 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Inspira Technologies OXY B.H.N.
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Inspira Technologies OXY B.H.N. has a net margin of 0.00% compared to Hyperfine's net margin of -210.75%. Inspira Technologies OXY B.H.N.'s return on equity of 0.00% beat Hyperfine's return on equity.

Company Net Margins Return on Equity Return on Assets
Hyperfine-210.75% -97.88% -61.81%
Inspira Technologies OXY B.H.N. N/A N/A N/A

Summary

Inspira Technologies OXY B.H.N. beats Hyperfine on 7 of the 13 factors compared between the two stocks.

Get Inspira Technologies OXY B.H.N. News Delivered to You Automatically

Sign up to receive the latest news and ratings for QTEX and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding QTEX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

QTEX vs. The Competition

MetricInspira Technologies OXY B.H.N.Healthcare Equipment & Supplies IndustryHealthcare SectorNASDAQ Exchange
Market Cap$33.35M$5.82B$7.32B$12.82B
Dividend YieldN/A1.74%2.54%10.69%
P/E RatioN/A26.20271.2024.12
Price / Sales115.0268.66598.4779.34
Price / CashN/A33.5178.1353.57
Price / Book15.465.9413.456.39
Net Income-$13.22M$148.91M$3.46B$347.50M
7 Day Performance-5.32%1.14%2.10%-0.01%
1 Month Performance-21.37%6.82%5.02%2.04%
1 Year PerformanceN/A9.29%27.65%20.48%

Inspira Technologies OXY B.H.N. Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
QTEX
Inspira Technologies OXY B.H.N.
0.1205 of 5 stars
$0.93
+9.1%
N/AN/A$33.35M$290KN/A20
APYX
Apyx Medical
2.4334 of 5 stars
$2.99
-1.0%
$6.60
+120.7%
+49.3%$127.21M$52.84MN/A270
MBOT
Microbot Medical
1.8976 of 5 stars
$1.74
+3.3%
$6.63
+281.8%
-55.0%$112.84MN/AN/A20
KEQU
Kewaunee Scientific
1.0431 of 5 stars
$36.23
+0.1%
N/A-36.0%$103.84M$282M11.251,231
LUNG
Pulmonx
2.5676 of 5 stars
$2.29
+1.3%
$7.67
+234.8%
+52.3%$97.06M$90.50MN/A250

Related Companies and Tools


This page (NASDAQ:QTEX) was last updated on 8/21/2026 by MarketBeat.com Staff.
From Our Partners